Document is current
Any future updates will be listed below
-
Authors
Sankar, Anjali http://orcid.org/0000-0002-7517-9776
Ziersen, Simon C.
Ozenne, Brice
Dam, Vibeke H.
Beaman, Emily E.
Kessing, Lars V.
Fisher, Patrick. M.
Budtz-Jørgensen, Esben
Knudsen, Gitte M. http://orcid.org/0000-0003-1508-6866
Miskowiak, Kamilla W.
Frokjaer, Vibe G.
-
Funding
Funding for this research was provided by:
Lundbeckfonden (R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145)
Innovationsfonden (4108-00004B, 4108-00004B, 4108-00004B)
- License Information
-
More Information
Article History
Received: 14 September 2023
Accepted: 12 July 2024
First Online: 26 August 2024
Competing interests
: G.M.K. has received honoraria as a speaker for Sage Therapeutics, Angelini and H. Lundbeck and as an expert advisor for Sanos, Onsero, Pangea, Pure and Gilgamesh. V.G.F. has served as a consultant for Sage therapeutics, H. Lundbeck, Janssen-Cilag and Gedeon Richter. K.W.M. has received consultancy fees from Lundbeck, Janssen and Angelini Pharma in the past 3 years. All other authors declare no conflicts of interest.
